$CGEN

Compugen Ltd

Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Holon, Israel

CGEN chart

What traders are saying about $CGEN

Latest posts

Compugen Ltd news

Compugen Ltd key financials

USD2025202420232022
Revenue$72.8M$27.9M$33.5M$7.5M
Net income$35.3M-$14.2M-$18.8M-$33.7M
Diluted EPS$0.38$-0.16$-0.21$-0.39
Total assets (year end)$156.6M$115.0M$121.3M$94.2M
Cash and equivalents (year end)$90.6M$18.2M$13.9M$11.1M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Compugen Ltd

Ticker
CGEN (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Holon, Israel
Incorporated in
Israel
Fiscal year end
December 31
SEC CIK
1119774

Frequently asked questions

What exchange is Compugen Ltd listed on?

Compugen Ltd trades on the Nasdaq under the ticker symbol CGEN.

What industry is Compugen Ltd in?

Compugen Ltd is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.

Where is Compugen Ltd headquartered?

Compugen Ltd's business address on file with the SEC is in Holon, Israel.

When does Compugen Ltd's fiscal year end?

Compugen Ltd's fiscal year ends on December 31.

How much revenue did Compugen Ltd report?

Compugen Ltd reported $72.8M in revenue for calendar year 2025, according to its SEC filings.